Global Fund To Fight Aids Tuberculosis And Malaria: $6.3B Revenue, $5.0B Expenses
Switzerland, Unknown · EIN 980380092 · Filing year 2023
Global Fund To Fight Aids Tuberculosis And Malaria reported $6.3B in total revenue, $5.0B in total expenses, and $9.3B in total assets on its 2023 IRS Form 990. Total compensation for current officers and key employees was $9.2M (0.15% of revenue). NonprofitTruth efficiency grade: B (79/100).
Source: ProPublica Nonprofit Explorer — IRS Form 990 filings, filing year 2023.
Key Facts (2023 Form 990)
- Total Revenue
- $6.3B
- Total Expenses
- $5.0B
- Total Assets
- $9.3B
- Reserve Months
- 22.1 months
- Surplus / (Deficit)
- $1.3B
- EIN
- 980380092
- Latest 990 Year
- 2023
- Current-Officer Compensation
- $9.2M
- Officer Comp % of Revenue
- 0.15%
The efficiency rubric puts Global Fund To Fight Aids Tuberculosis And Malaria at a B grade: a composite of 79/100 that lands above the national midpoint. The grade reflects solid financial reserves alongside reasonable officer compensation and steady revenue.
On revenue, Global Fund To Fight Aids Tuberculosis And Malaria is among the largest U.S. nonprofits: $6.3B in 2023 reported revenue. Organizations at this scale typically operate hospitals, university systems, or national federations — the financial pattern looks more like a corporation than the small-charity stereotype. Financial health is a strength: Global Fund To Fight Aids Tuberculosis And Malaria carries a healthy operating-reserve cushion against $5.0B in annual expenses, the kind of balance-sheet stability that helps an organization weather funding gaps without cutting programs.
Five-year revenue trajectory is strongly positive: Global Fund To Fight Aids Tuberculosis And Malaria has grown materially in real terms, which usually signals successful fundraising and program expansion. Officer compensation is modest relative to organizational size: Global Fund To Fight Aids Tuberculosis And Malaria reports $9.2M in total compensation for current officers and key employees (Form 990 Part IX, line 5) against $6.3B in revenue. The ratio is well within the bands third-party charity raters consider reasonable at this scale. Global Fund To Fight Aids Tuberculosis And Malaria is in the Medical Research category — public-affairs, civic, and research-policy organizations. The sector includes think tanks, advocacy organizations, and policy-research nonprofits.
How Global Fund To Fight Aids Tuberculosis And Malaria Compares
Global Fund To Fight Aids Tuberculosis And Malaria earns a NonprofitTruth efficiency grade of B (79/100). That is 1 points below the Medical Research category average. Compensation for current officers and key employees represents 0.15% of total revenue. The organization holds 22.1 months of operating reserves, indicating strong financial cushion.
990 Financial Snapshot
Based on IRS tax-exempt organization data, Global Fund To Fight Aids Tuberculosis And Malaria reported $6.3B in revenue against $5.0B in total functional expenses for filing year 2023, holding roughly 22.1 months of operating reserves. A program-vs-overhead split is not shown here because total program service expenses (Form 990 Part IX, line 25, column B) are not available in the ProPublica Nonprofit Explorer feed this site ingests; that breakdown can be read directly from the organization’s e-filed 990.
The 990 reports $9.2M in total compensation for current officers, directors, trustees, and key employees (Part IX, line 5) — 0.15% of total revenue. This is an aggregate across all listed officers; per-person amounts appear on Schedule J.
Revenue History
Get Global Fund To Fight Aids Tuberculosis And Malaria's next Form 990 grade
Subscribe for NonprofitTruth updates by email. No spam, unsubscribe anytime.
Global Fund To Fight Aids Tuberculosis And Malaria has a NonprofitTruth Efficiency Score of B (79/100), a financial-structure summary based on operating reserves, multi-year revenue consistency, and officer compensation relative to revenue — all drawn from the organization's IRS Form 990.
Global Fund To Fight Aids Tuberculosis And Malaria, Donor FAQ
Global Fund To Fight Aids Tuberculosis And Malaria has a NonprofitTruth Efficiency Score of B (79/100), a financial-structure summary based on operating reserves, multi-year revenue consistency, and officer compensation relative to revenue — all drawn from the organization's IRS Form 990.
Global Fund To Fight Aids Tuberculosis And Malaria reports $9.2M in total compensation for current officers, directors, trustees, and key employees (IRS Form 990 Part IX, line 5), representing 0.15% of the organization's $6.3B in annual revenue. This is an aggregate figure for all listed officers, not a single executive's salary; per-person pay is detailed on Schedule J of the 990.
Global Fund To Fight Aids Tuberculosis And Malaria reported $6.3B in annual revenue and $5.0B in total expenses for filing year 2023. The organization holds $9.3B in total assets.
Global Fund To Fight Aids Tuberculosis And Malaria holds approximately 22.1 months of operating reserves (total assets relative to annual expenses) based on its 2023 IRS Form 990, one input into its B efficiency grade.
Global Fund To Fight Aids Tuberculosis And Malaria is a registered 501(c) organization with EIN 980380092, based in Switzerland, Unknown. Financial data is sourced from publicly available IRS 990 filings via ProPublica Nonprofit Explorer.
Similar Medical Research Nonprofits
Financial data is sourced from IRS Form 990 filings via ProPublica Nonprofit Explorer. The Efficiency Score combines three signals the 990 feed actually reports: financial health / operating reserves (40%), multi-year revenue consistency (35%), and current-officer compensation relative to revenue (25%). It does not include a program-spending ratio, because total program service expenses are not exposed by the ProPublica feed; no program ratio is estimated. Filing data may lag 6-18 months from the tax year.